AHMEDABAD, 2 AUGUST

IMPORTANT EX-DIVIDEND TODAY

AJMERA REALTYRs 4
ALBERT DAVIDRs 11.5
CELLO WORLDRs 1.5
CIPLARs 13
COFORGERs 19
DIVIS LABRs 30
GLOSTERRs 20
INDIGO PAINTSRs 3.5
JUBILANT INGREVIARs 2.5
JUBILANT PHARMOVARs 5
MARUTI SUZUKIRs 125
MATRIMONYRs 5
MUNJAL SHOWARs 4.5
NARAYANA HRUDAYALAYARs 4
VEDANTARs 4
WPILRs 20

BRITANNIA: Revenue expected at Rs 4191 crore versus Rs 4010 crore,  EBITDA expected to be seen at Rs 777 crore versus Rs 688 crore,  EBITDA margin expected to be seen at 18.53 % versus 17.15 %

 Net profit expected to be seen at Rs 530 crore versus Rs 457 crore

HINDZINC

 Revenue expected at Rs 7915 crore versus Rs 7282 crore

 EBITDA expected to be seen at Rs 3982 crore versus Rs 3347 crore

 EBITDA margin expected to be seen at 50.30 % versus 45.96 %

 Net profit expected to be seen at Rs 2273 crore versus Rs 1964 crore

LICHSGFIN

 NII expected at Rs 2187 crore versus Rs 2209 crore

 EBIT expected to be seen at Rs 1915 crore versus Rs 2009 crore

 EBIT margin expected to be seen at 86.37 % versus 89.20 %

 Net profit expected to be seen at Rs 1230 crore versus Rs 1323 crore

TITAN

  2.8.2024

 Revenue expected at Rs 11,993 crore versus Rs 11,897 crore

 EBITDA expected to be seen at Rs 1162 crore versus Rs 1125 crore

 EBITDA margin expected to be seen at 9.69 % versus 9.45 %

 Net profit expected to be seen at Rs 764 crore versus Rs 753 crore

02.08.2024:AEROFLEX, BRITANNIA, CAMS, DALMIASUG, DELHIVERY, DHAMPURSUG, DHANUKA, HINDZINC, IDFC, INFIBEAM, IONEXCHANG, KIRLOSBROS, LICHSGFIN, MEDPLUS, PAUSHAKLTD, PSPPROJECT, RANEHOLDIN, RENUKA, SAMHI, SFL, SHARDAMOTR, SMLISUZU, SUDARSCHEM, TAJGVK, TEXINFRA, TITAN, TMB, UPL, ZYDUSWELL

UPL

 Revenue expected at Rs 8833 crore versus Rs 8963 crore

 EBITDA expected to be seen at Rs 1153 crore versus Rs 1592 crore

 EBITDA margin expected to be seen at 13.05 % versus 17.76 %

 Net profit expected to be seen at Rs (313) crore versus Rs 209 crore

03.08.2024AFFLE,ARE&M, BANKINDIA, CGCL, DIVISLAB, EVEREADY, GAEL, GOKULAGRO, HIMATSEIDE, JKTYRE, KUANTUM, NUCLEUS, SARDAEN, SBIN, UTKARSHBNK, ZUARI

ARE&M

 Revenue expected at Rs 3083 crore versus Rs 2769 crore

 EBITDA expected to be seen at Rs 454 crore versus Rs 353 crore

 EBITDA margin expected to be seen at 14.72% versus 12.74%

 Net profit expected to be seen at Rs 264 crore versus Rs 192 crore

DIVISLAB

 Revenue expected at Rs 2060 crore versus Rs 1778 crore

 EBITDA expected to be seen at Rs 615 crore versus Rs 504 crore

 EBITDA margin expected to be seen at 29.85% versus 28.34%

 Net profit expected to be seen at Rs 445 crore versus Rs 356 crore

JKTYRE

 Revenue expected at Rs 3874 crore versus Rs 3718 crore

 EBITDA expected to be seen at Rs 505 crore versus Rs 685 crore

 EBITDA margin expected to be seen at 13.03% versus 18.42%

 Net profit expected to be seen at Rs 207 crore versus Rs 149 crore

SBIN

 NII expected at Rs 41, 990 crore versus Rs 38,905 crore

 EBIT expected to be seen at Rs 25,431 crore versus Rs 22,795 crore

 EBIT margin expected to be seen at 47.27% versus 44.72%

 Net profit expected to be seen at Rs 16,867 crore versus Rs 16,884 crore

05.08.2024:ARTIPHARM, ANDHRAPAP, AVANTIFEED, BEML, BHARTIARTL, BHARTIHEXA, BLS, BLSE, BRIGADE, CENTURYPLY, CUPID, DEEPAKNTR, DEEPINDS, DEVYANI, EIHAHOTELS, EXICOM, GSFC, HAWKINCOOK, HCC, HGINFRA, HONAUT, INDRAMEDCO, MANGLMCEM, MARICO, MSUMI, MUKANDLTD, ONGC, ORIENTCEM, PARAS, REFEX, RUSTOMJEE, SANDUMA, SCHNEIDER, SDBL, SMSPHARMA, SPARC, SUVEN, SYRMA, TAJGVK, TATACHEM, TRITURBINE, VIJAYA, VMART, VRLLOG

BHARTIARTL

 Revenue expected at Rs 38,530 crore versus Rs 37,440 crore

 EBITDA expected to be seen at Rs 19,970 crore versus Rs 19,598 crore

 EBITDA margin expected to be seen at 51.82% versus 52.34%

 Net profit expected to be seen at Rs 3785 crore versus Rs 5028 crore

DEEPAKNTR

 Revenue expected at Rs 2070 crore versus Rs 1768 crore

 EBITDA expected to be seen at Rs 316 crore versus Rs 209 crore

 EBITDA margin expected to be seen at 15.26% versus 11.82%

 Net profit expected to be seen at Rs 207 crore versus Rs 149 crore

MARICO

 Revenue expected at Rs 2660 crore versus Rs 2477 crore

 EBITDA expected to be seen at Rs 627 crore versus Rs 574 crore

 EBITDA margin expected to be seen at 23.57% versus 23.17%

 Net profit expected to be seen at Rs 462 crore versus Rs 427 crore

MSUMI               

 Revenue expected at Rs 2219 crore versus Rs 1858 crore

 EBITDA expected to be seen at Rs 271 crore versus Rs 194 crore

 EBITDA margin expected to be seen at 12.21% versus 10.44%

 Net profit expected to be seen at Rs 174 crore versus Rs 123 crore

TATACHEM        

 Revenue expected at Rs 3686 crore versus Rs 4218 crore

 EBITDA expected to be seen at Rs 511 crore versus Rs 1043 crore

 EBITDA margin expected to be seen at 13.86% versus 24.72%

 Net profit expected to be seen at Rs 114 crore versus Rs 523 crore

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)